TScan Therapeutics (TCRX) Asset Utilization Ratio (2021 - 2026)
TScan Therapeutics' (TCRX) quarterly Asset Utilization Ratio came in at 0.04 in Q1 2026, up 237.63% year-on-year from 0.01 in Q1 2025, and up 0.86% on a QoQ basis from 0.04 in Q4 2025.
TScan Therapeutics (TCRX) Asset Utilization Ratio (2021 - 2026) Analysis & Trends
TScan Therapeutics (TCRX) has 6 years of Asset Utilization Ratio data on file, last reported at 0.04 in Q1 2026.
- On a quarterly basis, Asset Utilization Ratio rose 237.63% year-over-year to 0.04 in Q1 2026; TTM through Mar 2026 was 0.04, a 237.63% increase from a year earlier, with the FY2025 full-year figure at 0.03, up 293.16% from the prior year.
- Asset Utilization Ratio for Q1 2026 stood at 0.04, up from 0.04 in the prior quarter.
- Over the last five years, Asset Utilization Ratio for TCRX reached as high as 0.09 in Q1 2023 and fell as low as 0.01 in Q4 2024.
- Historically, Asset Utilization Ratio has averaged 0.05 across 5 years, with a median of 0.05 in 2023.
- Across the five-year window, Asset Utilization Ratio sank 88.99% in 2024 and jumped 437.01% in 2025, its largest moves.
- Year by year, Asset Utilization Ratio stood at 0.07 in 2022, then fell by 4.19% to 0.07 in 2023, then sank by 88.99% to 0.01 in 2024, then jumped by 437.01% to 0.04 in 2025, then climbed by 0.86% to 0.04 in 2026.
- Per Business Quant data, the three most recent Asset Utilization Ratio figures were 0.04 in Q1 2026, 0.04 in Q4 2025, and 0.03 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 0.69 |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 0.47 |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 0.37 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | TScan Therapeutics | 100.59 Mn | -27.47 Mn | - | 0.04 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.04 |
| Dec 31, 2025 | 0.04 |
| Sep 30, 2025 | 0.03 |
| Jun 30, 2025 | 0.02 |
| Mar 31, 2025 | 0.01 |
| Dec 31, 2024 | 0.01 |
| Sep 30, 2024 | 0.03 |
| Jun 30, 2024 | 0.04 |
| Mar 31, 2024 | 0.06 |
| Dec 31, 2023 | 0.07 |
| Sep 30, 2023 | 0.05 |
| Jun 30, 2023 | 0.06 |
| Mar 31, 2023 | 0.09 |
| Dec 31, 2022 | 0.07 |
| Sep 30, 2022 | 0.08 |
| Jun 30, 2022 | 0.08 |
| Mar 31, 2022 | 0.06 |
| Dec 31, 2021 | 0.05 |
| Sep 30, 2021 | 0.05 |